Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)
Altogether, the BELCOMID study provides evidence for the efficacy and safety of COVID-19 vaccination and confirms the importance of repeated booster vaccination in IMID patients.
Authors
- Triana Lobatón (ORCID: https://orcid.org/0000-0003-1817-7704)
- Jo Lambert (ORCID: https://orcid.org/0000-0001-5303-9310)
- Severine A.R.A. Vermeire (ORCID: https://orcid.org/0000-0001-9942-3019)
- Elizaveta Padalko (ORCID: https://orcid.org/0000-0002-8101-6957)
- An Van Laethem
- Marc Ferrante (ORCID: https://orcid.org/0000-0003-1492-0716)
- Hilde Lapeere (ORCID: https://orcid.org/0000-0003-4319-4776)
- Marie Truyens (ORCID: https://orcid.org/0000-0002-1264-4319)
- Tom Hillary (ORCID: https://orcid.org/0000-0002-4497-8487)
- Jeroen Geldof (ORCID: https://orcid.org/0000-0003-0126-2929)
- João Sabino (ORCID: https://orcid.org/0000-0002-8892-7075)
- Kurt de Vlam (ORCID: https://orcid.org/0000-0003-3848-5122)
- Patrick Verschueren (ORCID: https://orcid.org/0000-0002-0340-3580)
Institutions
- Ghent University Hospital (BE)
- Ghent University (BE)
- KU Leuven (BE)
Publication Details
- Journal
- Vaccines
- Published
- 2024-10-11
- DOI
- https://doi.org/10.3390/vaccines12101157
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Universiteit Gent